NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.24
-0.65 (-1.86%)
At close: Feb 11, 2026, 4:00 PM EST
34.31
+0.07 (0.20%)
After-hours: Feb 11, 2026, 4:13 PM EST
NAMS Market Cap
NAMS has a market cap or net worth of $3.88 billion as of February 11, 2026. Its market cap has increased by 60.40% in one year.
Market Cap
3.88B
Enterprise Value
3.13B
1-Year Change
60.40%
Ranking
Category
Stock Price
$34.24
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.88B, an increase of 2,413.77%. That is a compound annual growth rate of 90.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.96B | -0.54% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 4.32B |
| Corcept Therapeutics | 4.29B |
| TG Therapeutics | 4.21B |
| Terns Pharmaceuticals | 4.20B |
| Arcellx | 4.04B |
| ADMA Biologics | 3.87B |
| ACADIA Pharmaceuticals | 3.80B |
| Ligand Pharmaceuticals | 3.66B |